Vaccination strategies for epidemic cholera in Haiti with implications for the developing world

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 17, 2011, Pages 7081-7085

  Chao, Dennis L ^a   Halloran, M Elizabeth ^a,b   Longini Jr , Ira M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Infectious diseases; Simulation modeling

Indexed keywords

CHOLERA VACCINE;

ARTICLE; CHOLERA; DEVELOPING COUNTRY; ENVIRONMENTAL SANITATION; EPIDEMIC; HAITI; HIGH RISK POPULATION; HUMAN; MATHEMATICAL MODEL; NONHUMAN; POPULATION EXPOSURE; PRIORITY JOURNAL; SIMULATION; VACCINATION; VIBRIO CHOLERAE;

CHOLERA; CHOLERA VACCINES; DEVELOPING COUNTRIES; EPIDEMICS; FEMALE; HAITI; HUMANS; MALE; MODELS, BIOLOGICAL; VACCINATION; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 79955559401     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1102149108     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention (CDC) (2010) Cholera outbreak - Haiti, October 2010. MMWR Morb Mortal Wkly Rep 59:1411.
2. Chin CS, et al. (2011) The origin of the Haitian cholera outbreak strain. N Engl J Med 364:33-42.
3. Ministère de la Santé Publique et de la Population (MSPP) (2011) Rapport journalier MSPP du 14 février 2011. Available at http://www.mspp.gouv.ht/site/downloads/ Rapport%20journalier%20MSPP%20du%2014%20fevrier%202011.pdf. Accessed February 21, 2011.
4. Waldor MK, Hotez PJ, Clemens JD (2010) A national cholera vaccine stockpile - a new humanitarian and diplomatic resource. N Engl J Med 363:2279-2282.
5. Nair GB, et al. (2006) Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol 44:4211-4213.
6. Bhattacharya S, et al. (2009) Public health. The cholera crisis in Africa. Science 324:885.
7. Siddique AK, et al. (2010) El Tor cholera with severe disease: A new threat to Asia and beyond. Epidemiol Infect 138:347-352.
8. Ivers LC, Farmer P, Almazor CP, Léandre F (2010) Five complementary interventions to slow cholera: Haiti. Lancet 376:2048-2051.
9. Clemens JD, et al. (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335:270-273. (Pubitemid 20047723)
10. Lopez AL, Clemens JD, Deen J, Jodar L (2008) Cholera vaccines for the developing world. Hum Vaccin 4:165-169. (Pubitemid 351881187)
11. World Health Organization (2010) Oral Cholera Vaccines in Mass Immunization Campaigns: Guidance for Planning and Use (World Health Organization, Geneva).
12. Cyranoski D (2011) Cholera vaccine plan splits experts. Nature 469:273-274.
13. Legros D, et al. (1999) Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ 77:837-842.
14. Jeuland M, et al. (2009) Cost-effectiveness of new-generation oral cholera vaccines: A multisite analysis. Value Health 12:899-908.
15. Chaignat CL, Monti V (2007) Use of oral cholera vaccine in complex emergencies: What next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr 25:244-261.
16. Halloran ME, Longini IM, Jr., Struchiner CJ (2010) Design and Analysis of Vaccine Studies (Springer, New York).
17. King AA, Ionides EL, Pascual M, Bouma MJ (2008) Inapparent infections and cholera dynamics. Nature 454:877-880.
18. Griffith DC, Kelly-Hope LA, Miller MA (2006) Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg 75:973-977. (Pubitemid 351627552)
19. Huq A, et al. (2005) Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol 71:4645-4654. (Pubitemid 41129521)
20. Constantin de Magny G, et al. (2008) Environmental signatures associated with cholera epidemics. Proc Natl Acad Sci USA 105:17676-17681.
21. Ali M, et al. (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: A reanalysis. Lancet 366:44-49. (Pubitemid 40956529)
22. Longini IM, Jr., et al. (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4:e336.
23. Harris JB, et al. (2008) Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis 2:e221.
24. Durham LK, et al. (1998) Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines. Am J Epidemiol 147:948-959.
25. Luby SP, Mendoza C, Keswick BH, Chiller TM, Hoekstra RM (2008) Difficulties in bringing point-of-use water treatment to scale in rural Guatemala. Am J Trop Med Hyg 78:382-387. (Pubitemid 351845184)
26. Hartley DM, Morris JG, Jr., Smith DL (2006) Hyperinfectivity: A critical element in the ability of V. cholerae to cause epidemics? PLoS Med 3:e7.
27. Black RE, et al. (1987) Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect Immun 55:1116-1120. (Pubitemid 17065660)